Ramace 1.25 Tablet
By Ramace
Rx
10 Tablet in a Strip

Composition
Ramipril(1.25mg)

Manufacturer - AstraZeneca
Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

Expires on or after
August, 2025

liver
When taking Ramace 1.25 Tablet, it is essential to be cautious if you have liver disease. In such cases, your doctor may need to adjust the dose of the medication. Make sure to inform your doctor if you notice any signs or symptoms of jaundice while using Ramace 1.25 Tablet. It is advisable to seek medical advice and supervision to ensure the safety and effectiveness of the treatment in relation to liver health.

kidney
Ramace 1.25 Tablet should be used carefully in patients with kidney disease. Adjusting the dose may be necessary, so consult your doctor. Regularly monitor blood pressure for dose adjustments.

alcohol
Ramace 1.25 Tablet can lead to increased drowsiness when taken with alcohol. It is important to be cautious when consuming alcohol while on this medication.

driving
Ramace 1.25 Tablet may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Ramace 1.25 Tablet is not recommended during pregnancy due to potential risk to the baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Ramace 1.25 Tablet is considered unsafe during breastfeeding. Limited human data indicates potential transfer of the drug into breastmilk, posing a risk to the baby.
Habit Forming | No |
Chemical Class | Dipeptides (Carboxylic acids derivatives) |
Therapeutic Class | CARDIAC |
Action Class | Angiotensin-converting enzyme (ACE) inhibitors |
₹35
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024